FDA Determines Regulatory Review Period for LEA'S SHIELD Patent Extension

Summary

The US Food and Drug Administration (FDA) has officially confirmed the regulatory review period for the patent extension of LEA'S SHIELD, a medical device, in accordance with federal regulations and law requirements.